Peripheral blood versus bone marrow transplant in patients with aplastic anemia, an unresolved issue

Bone Marrow Transplant. 2016 Dec;51(12):1628-1630. doi: 10.1038/bmt.2016.235. Epub 2016 Sep 26.

Authors

A Ghavamzadeh¹, K Alimoghaddam¹, M Jalili¹, S A Mousavi¹, B Bahar¹, A Kasaeian^{1

2}, A A Hamidieh¹, M Behfar¹, M Vaezi¹, A Jalali³, M Jahani¹

Affiliations

¹ Hematology-Oncology and Stem Cell Transplantation Research Center/Tehran University of Medical Sciences, Tehran, Iran.
² Non-communicable Diseases Research Center, Endocrinology & Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
³ Tehran University of Medical Sciences, Tehran, Iran.

PMID: 27668763
DOI: 10.1038/bmt.2016.235

No abstract available

MeSH terms

Adolescent
Anemia, Aplastic / therapy*
Antigens, CD34 / metabolism
Bone Marrow Transplantation / methods*
Cyclophosphamide / therapeutic use
Disease-Free Survival
Female
Follow-Up Studies
HLA Antigens / chemistry
Hematopoietic Stem Cell Mobilization
Hematopoietic Stem Cell Transplantation / methods
Hospitalization
Humans
Immunosuppressive Agents / therapeutic use
Male
Multivariate Analysis
Peripheral Blood Stem Cell Transplantation / methods*
Proportional Hazards Models
Risk
Transplantation Conditioning / methods
Treatment Outcome
Young Adult

Substances

Antigens, CD34
HLA Antigens
Immunosuppressive Agents
Cyclophosphamide